Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blind Control Trial of Transdermal Testosterone Supplementation vs Placebo on Follicular Development and Atresia, Oocyte and Embryo Quality Among Women With Diminished Ovarian Reserve Undergoing in Vitro Fertilization

NCT01662466 is registered in ClinicalTrials.gov with Center for Human Reproduction as lead sponsor.

NCT NCT01662466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01662466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blind Control Trial of Transdermal Testosterone Supplementation vs Placebo on Follicular Development and Atresia, Oocyte and Embryo Quality Among Women With Diminished Ovarian Reserve Undergoing in Vitro Fertilization
Lead sponsor
Center for Human Reproduction
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 1, 2012
Completion date
December 31, 2022
Enrollment
180 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

female infertility due to diminished ovarian reserve, primary ovarian insufficiency